Vynleads Inc
Vynleads, Inc. provides health and wellness information to prediabetic individuals or type 2 diabetes sufferers in the United States. It offers Lifestyle Blueprint, a digital guide that provides dietary recommendations for a very low calorie eight-week diet, as well as nutritional information. The company sells nutritional supplements; and monthly subscriptions to proprietary newsletter that cove… Read more
Vynleads Inc (VYND) - Net Assets
Latest net assets as of September 2025: $-325.99K USD
Based on the latest financial reports, Vynleads Inc (VYND) has net assets worth $-325.99K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($40.75K) and total liabilities ($366.74K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-325.99K |
| % of Total Assets | -799.9% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 138.5 |
Vynleads Inc - Net Assets Trend (2016–2024)
This chart illustrates how Vynleads Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Vynleads Inc (2016–2024)
The table below shows the annual net assets of Vynleads Inc from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-227.37K | +70.43% |
| 2023-12-31 | $-768.93K | -21.00% |
| 2022-12-31 | $-635.49K | -29.20% |
| 2021-12-31 | $-491.87K | -40.42% |
| 2020-12-31 | $-350.29K | -158.78% |
| 2019-12-31 | $-135.36K | -367.02% |
| 2018-12-31 | $50.69K | -90.03% |
| 2017-12-31 | $508.23K | +743.17% |
| 2016-12-31 | $-79.02K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Vynleads Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 270650800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $2.56 Million | % |
| Total Equity | $-227.37K | 100.00% |
Vynleads Inc Competitors by Market Cap
The table below lists competitors of Vynleads Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
State GAS Ltd
AU:GAS
|
$4.68 Million |
|
ACC Aviation Holdings Ltd
PINK:CAVG
|
$4.68 Million |
|
Southern Banc Company Inc
PINK:SRNN
|
$4.68 Million |
|
Copper Quest Exploration Inc.
F:3MX0
|
$4.68 Million |
|
Catcha Digital Bhd
KLSE:0173
|
$4.68 Million |
|
Biomotion Sciences Ordinary Shares
NASDAQ:SLXN
|
$4.67 Million |
|
Mako Gold Ltd
AU:MKG
|
$4.67 Million |
|
LogProstyle Inc.
NYSE MKT:LGPS
|
$4.67 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vynleads Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -768,926 to -227,365, a change of 541,561.
- Net loss of 261,192 reduced equity.
- New share issuances of 100,000 increased equity.
- Other factors increased equity by 702,753.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-261.19K | -114.88% |
| Share Issuances | $100.00K | +43.98% |
| Other Changes | $702.75K | +309.09% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Vynleads Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.04 | $0.50 | x |
| 2018-12-31 | $0.00 | $0.50 | x |
| 2019-12-31 | $-0.01 | $0.50 | x |
| 2020-12-31 | $-0.03 | $0.50 | x |
| 2021-12-31 | $-0.04 | $0.50 | x |
| 2022-12-31 | $-0.05 | $0.50 | x |
| 2023-12-31 | $-0.07 | $0.50 | x |
| 2024-12-31 | $-0.01 | $0.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Vynleads Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-123.43%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.27% | 14.63x | 0.00x | $13.84K |
| 2017 | -85.42% | -16.09% | 4.50x | 1.18x | $-484.96K |
| 2018 | -1025.47% | -28.51% | 10.57x | 3.40x | $-524.91K |
| 2019 | 0.00% | -76.40% | 3.53x | 0.00x | $-289.53K |
| 2020 | 0.00% | -786.60% | 1.27x | 0.00x | $-344.60K |
| 2021 | 0.00% | -56111.78% | 0.02x | 0.00x | $-222.39K |
| 2022 | 0.00% | -558414.29% | 0.00x | 0.00x | $-210.07K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-186.54K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-238.46K |
Industry Comparison
This section compares Vynleads Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Vynleads Inc (VYND) | $-325.99K | 0.00% | N/A | $4.68 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |